Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Key immune driver of pancreatic cancer points to combination treatment for slowing progression

Researchers from The University of Texas MD Anderson Cancer Center have discovered that the IL-18 inflammatory protein helps pancreatic tumors grow and evade the immune system, highlighting its potential as a therapeutic target for pancreatic cancer.

Key immune driver of pancreatic cancer points to combination treatment for slowing progression

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

More from Tuesday 17 November →